Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

1.0K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.0K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

676
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
676
Regulation of Food Intake01:30

Regulation of Food Intake

2.1K
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
2.1K
Hypothalamic-Pituitary Axis01:37

Hypothalamic-Pituitary Axis

64.8K
The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
64.8K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

767
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
767
Diencephalon: Hypothalamus and Coordination01:23

Diencephalon: Hypothalamus and Coordination

3.2K
The hypothalamus is a small yet highly complex and essential brain region that plays a crucial role in regulating various bodily functions. Anatomically, it is located at the base of the brain, just above the brainstem and below the thalamus, forming part of the limbic system.
The hypothalamus interacts with other brain regions, including the pituitary gland, through a direct physical connection called the hypothalamic-pituitary axis. The hypothalamus receives somatic and visceral inputs and...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Setmelanotide for the Treatment of Acquired Hypothalamic Obesity.

The New England journal of medicine·2026
Same author

Quality of life, morbidity, mortality, and long-term prognosis after craniopharyngioma.

Frontiers in endocrinology·2026
Same author

Expert meeting report: epidemiology and management of acquired hypothalamic obesity.

Frontiers in endocrinology·2026
Same author

Defining Acquired Hypothalamic Obesity: An Expert Call for Unified Diagnosis and Therapeutic Action.

Diabetes, obesity & metabolism·2026
Same author

Acute Toxicities During Proton Therapy with or Without Simultaneous Chemotherapy in Pediatric CNS Tumors: A Retrospective Cohort Study.

Cancers·2026
Same author

Current Approaches and Therapeutic Strategies for Hypothalamic Syndrome in Patients with Childhood-onset Craniopharyngioma.

Journal of clinical research in pediatric endocrinology·2026

Related Experiment Video

Updated: Dec 13, 2025

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

763

Management of Hypothalamic Obesity.

Hermann L Müller1

  • 1Department of Pediatrics and Pediatric Hematology/Oncology, University Children's Hospital, Klinikum Oldenburg AöR, Rahel-Straus-Strasse 10, Oldenburg 26133, Germany.

Endocrinology and Metabolism Clinics of North America
|August 4, 2020
PubMed
Summary

Hypothalamic obesity (HO) is a complex condition resulting from damage to the hypothalamus, often seen in craniopharyngioma (CP) patients. Current treatments are ineffective, making prevention of HO the recommended approach.

Keywords:
Bariatric surgeryCraniopharyngiomaHypothalamusObesityPituitary

More Related Videos

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

972
A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

1.2K

Related Experiment Videos

Last Updated: Dec 13, 2025

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

763
An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

972
A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

1.2K

Area of Science:

  • Neuroendocrinology
  • Oncology
  • Metabolic disorders

Background:

  • Energy homeostasis, appetite, and satiety are regulated by the hypothalamus.
  • Hypothalamic obesity (HO) arises from dysregulation of this system due to brain tumors, surgery, or irradiation.
  • Craniopharyngioma (CP) frequently leads to HO due to direct hypothalamic involvement or treatment effects.

Purpose of the Study:

  • To review the challenges in managing hypothalamic obesity (HO) in craniopharyngioma (CP) patients.
  • To evaluate the efficacy of current interventions for HO.
  • To emphasize the importance of HO prevention strategies.

Main Methods:

  • Literature review of studies on hypothalamic obesity and craniopharyngioma.
  • Analysis of treatment outcomes for lifestyle, pharmacologic, and bariatric interventions.
  • Synthesis of evidence regarding the causes and management of HO.

Main Results:

  • Lifestyle interventions have shown unsatisfactory results in controlling HO.
  • No pharmacologic or bariatric therapies have proven effective in randomized controlled trials for HO in CP.
  • Hypothalamic damage from CP and its treatments is a primary cause of HO.

Conclusions:

  • Effective treatments for established hypothalamic obesity are lacking.
  • Prevention of HO in patients with craniopharyngioma is crucial.
  • Further research into preventative measures is warranted.